citalopram has been researched along with Birth Weight in 3 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pregnant women who contacted the Motherisk Program, a Teratogen Information Center in Toronto, Ontario, with regard to the safety of citalopram in pregnancy were enrolled in the study." | 7.73 | Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. ( Einarson, A; Koren, G; Sarkissian, L; Shuhaiber, S; Sivojelezova, A, 2005) |
| "Escitalopram is a serotonin reuptake inhibitor prescribed for depression and anxiety." | 5.38 | Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study. ( Einarson, A; Einarson, T; Klieger-Grossmann, C; Koren, G; Panchaud, A; Pistelli, A; Weitzner, B, 2012) |
| "Pregnant women who contacted the Motherisk Program, a Teratogen Information Center in Toronto, Ontario, with regard to the safety of citalopram in pregnancy were enrolled in the study." | 3.73 | Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. ( Einarson, A; Koren, G; Sarkissian, L; Shuhaiber, S; Sivojelezova, A, 2005) |
| "Escitalopram is a serotonin reuptake inhibitor prescribed for depression and anxiety." | 1.38 | Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study. ( Einarson, A; Einarson, T; Klieger-Grossmann, C; Koren, G; Panchaud, A; Pistelli, A; Weitzner, B, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davidson, S | 1 |
| Prokonov, D | 1 |
| Taler, M | 1 |
| Maayan, R | 1 |
| Harell, D | 1 |
| Gil-Ad, I | 1 |
| Weizman, A | 1 |
| Klieger-Grossmann, C | 1 |
| Weitzner, B | 1 |
| Panchaud, A | 1 |
| Pistelli, A | 1 |
| Einarson, T | 1 |
| Koren, G | 2 |
| Einarson, A | 2 |
| Sivojelezova, A | 1 |
| Shuhaiber, S | 1 |
| Sarkissian, L | 1 |
3 other studies available for citalopram and Birth Weight
| Article | Year |
|---|---|
Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes.
Topics: Adult; Birth Weight; Case-Control Studies; Citalopram; Female; Fetal Blood; Fetal Development; Fetal | 2009 |
Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Abortion, Therapeutic; Analysis of Variance; Ant | 2012 |
Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome.
Topics: Antidepressive Agents, Second-Generation; Birth Weight; Citalopram; Female; Gestational Age; Humans; | 2005 |